Back
Trevena 10K Form
Sell
12
TRVN
Trevena
Last Price:
4.92
Seasonality Move:
-30.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-15 | 10Q | TRVN/Trevena Quarterly |
| 2023-11-14 | 10Q | TRVN/Trevena Quarterly |
| 2023-08-14 | 10Q | TRVN/Trevena Quarterly |
| 2023-05-15 | 10Q | TRVN/Trevena Quarterly |
| 2022-11-09 | 10Q | TRVN/Trevena Quarterly |
| 2022-08-11 | 10Q | TRVN/Trevena Quarterly |
Receive TRVN News And Ratings
See the #1 stock for the next 7 days that we like better than TRVN
TRVN Financial Statistics
Sales & Book Value
| Annual Sales: | $3.13M |
|---|---|
| Cash Flow: | $-7.18M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-22.23 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -57.25000 |
|---|---|
| Net Income (TTM): | $-37.03M |
| Gross Margin: | $1.46M |
| Return on Equity: | 0% |
| Return on Assets: | -103.61% |
Trevena Earnings Forecast
Key Trevena Financial Ratios
- The Gross Profit Margin over the past 9 years for TRVN is 46.56%.
- The Selling, General & Administrative Expenses for TRVN have been equal to 653.12% of Gross Profit Margin.
- The Research & Development expenses have been 522.66% of Revenue.
- The Interest Expense is -9.04% of Operating Income.
- The Net Earning history of TRVN is -1,289.25% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 9 years.
Trevena Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TRVN |
| CUSIP: | 89532E |
| Website: | trevena.com |
Debt
| Debt-to-Equity Ratio: | -1.66 |
|---|---|
| Current Ratio: | 3.46 |
| Quick Ratio: | 3.14 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |